...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30, 2019


BREAKING: Gratomic Signs Deal to Supply Graphite to Todaq

  • Signed an agreement with Todaq Star Program Phase 1 Corp. to supply Todaq with an aggregate of US$25,000,000 of graphite from its Aukam project in Namibia over approximately 39 months
  • Initial order will be for 600 tonnes of graphite valued at US$3,000,000 payable in TODA Notes, a digital asset created as a medium for exchange and store of value, at a price of US$0.10 per TDN for an aggregate of 30 million TDN
  • Initial 600 tonnes of graphite are to be delivered within 90 days
  • Graphite is being purchased by Todaq to sit in reserve as a backstop to underpin the value of deployed TDN

Gratomic large new

Hub On AGORACOM / Read Release

Message: 2019 Potential Events

"maybe they will be "nice" and tell us, or at least some type of forewarning that TLD will be announced (event/date/time) :)"

Lol. Probably the best we will get will be a re-assurance that top-line data announcement is still on track to be announced by end of September or end of Q3, assuming that there is no delay from the current guidance. 

To be a fly on the wall at ESC to see the attitudes and body language and to overhear the conversations amongst Resverlogix management, BETonMACE clinical steering committee, BETonMACE clinical investigators, etc. Good chance database will be locked and data unblinded for Resverlogix and BETonMACE clinical team around the time of ESC.


New Message
Please login to post a reply